Annual Operating Expenses
$15.98 M
+$3.39 M+26.93%
December 31, 2023
Summary
- As of February 8, 2025, KTTA annual total operating expenses is $15.98 million, with the most recent change of +$3.39 million (+26.93%) on December 31, 2023.
- KTTA annual operating expenses is now at all-time high.
Performance
KTTA Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$3.00 M
-$940.40 K-23.84%
September 30, 2024
Summary
- As of February 8, 2025, KTTA quarterly total operating expenses is $3.00 million, with the most recent change of -$940.40 thousand (-23.84%) on September 30, 2024.
- Over the past year, KTTA quarterly operating expenses has dropped by -$940.40 thousand (-23.84%).
- KTTA quarterly operating expenses is now -41.64% below its all-time high of $5.15 million, reached on December 31, 2023.
Performance
KTTA Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
KTTA Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +26.9% | -23.8% |
| 3 y3 years | - | -22.1% |
| 5 y5 years | - | -22.1% |
KTTA Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +254.7% | -41.6% | +53.8% |
| 5 y | 5-year | at high | +254.7% | -41.6% | >+9999.0% |
| alltime | all time | at high | +254.7% | -41.6% | >+9999.0% |
Pasithea Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $3.00 M(-23.8%) |
| Jun 2024 | - | $3.94 M(-2.4%) |
| Mar 2024 | - | $4.04 M(-21.5%) |
| Dec 2023 | $15.98 M(+26.9%) | $5.15 M(+35.9%) |
| Sep 2023 | - | $3.79 M(-1.0%) |
| Jun 2023 | - | $3.83 M(+19.2%) |
| Mar 2023 | - | $3.21 M(-20.5%) |
| Dec 2022 | $12.59 M | $4.04 M(+4.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $3.86 M(+47.6%) |
| Jun 2022 | - | $2.61 M(+25.6%) |
| Mar 2022 | - | $2.08 M(+6.4%) |
| Dec 2021 | $4.51 M | $1.95 M(+53.4%) |
| Sep 2021 | - | $1.27 M(+75.0%) |
| Jun 2021 | - | $727.90 K(+32.4%) |
| Mar 2021 | - | $549.60 K(+3825.7%) |
| Sep 2020 | - | $14.00 K |
FAQ
- What is Pasithea Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Pasithea Therapeutics?
- What is Pasithea Therapeutics annual operating expenses year-on-year change?
- What is Pasithea Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Pasithea Therapeutics?
- What is Pasithea Therapeutics quarterly operating expenses year-on-year change?
What is Pasithea Therapeutics annual total operating expenses?
The current annual operating expenses of KTTA is $15.98 M
What is the all time high annual operating expenses for Pasithea Therapeutics?
Pasithea Therapeutics all-time high annual total operating expenses is $15.98 M
What is Pasithea Therapeutics annual operating expenses year-on-year change?
Over the past year, KTTA annual total operating expenses has changed by +$3.39 M (+26.93%)
What is Pasithea Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of KTTA is $3.00 M
What is the all time high quarterly operating expenses for Pasithea Therapeutics?
Pasithea Therapeutics all-time high quarterly total operating expenses is $5.15 M
What is Pasithea Therapeutics quarterly operating expenses year-on-year change?
Over the past year, KTTA quarterly total operating expenses has changed by -$940.40 K (-23.84%)